The most investor-friendly segment of the fund industry.
Mutual fund management ain’t what it used to be.
There are now more reasons to worry about market glitches, but that doesn’t mean it makes sense to avoid stocks.
Those stock funds that moved less, profited more.
The mutual fund industry’s two indexing leaders have left different legacies.
Does benchmarking fund managers harm the financial markets?
A grand unified theory for bad market behavior.
Energy, crises, and strategic beta.
Examining relative versus absolute approaches to fund categorization.
But this year is different ... right?
Quite the opposite.
It promises what it can deliver.
Finance experts don't necessarily invest as they advise.
Energy is tempting, but its prospects are oh-so-uncertain.
Find the market's dummies, accept more risk, or use cash effectively.
But probably innocent.
A solution in search of a problem?
Will it spread to financial-advisory fees?
They have not generally, but that might be changing.
The evidence is mostly spurious.
Active U.S. stock funds haven't dodged the downturn.
The yield-curve indicator is not flashing...yet.
It may not be wise to seek the single "best" approach.
So, apparently, do some index funds.
The film is right, yet it is wrong.
The same questions must be answered.
Some things, but perhaps not what you think.
The business model exerts its effects.
It can make sense, if done with humility.
The curious tale of less-liquid stocks.
The (alleged) woes of finance professors.
Their relative performance keeps declining.
Skills, expenses, and taxes.
They are no worse (or better) than other forms of active management.
Not, it seems, with stock mutual funds.
Everyday investors will not wish to copy the famed pension funds, but they can pick up some tips.
Intel is about to find out.
Bogle’s forecasts may not be reliable guides for any specified time period, but they will likely be close to the mark over the longer term.
Surprisingly, the reason relates to income inequality.
The good news speaks quietly.
Probably not what your fund company says.
The evidence from three indicators.
On 401(k) fees, ESG strategies, and smart beta.
Why the trend is your friend.
Will this one work?
In a politicized discussion, the truth can be hard to find.
A worthwhile effort, but some questions remain.
Buy what others don't like.
Fidelity's "study" rings true, whether it exists or not.
His advice for avoiding "grievous harm."